1d
Clinical Trials Arena on MSNHelicore doses first subject in Phase I trial of obesity treatmentUS-based biopharmaceutical company Helicore Biopharma has dosed the first subject in a randomised, first-in-human Phase I ...
After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from early testing of an experimental Covid treatment.
Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.
4d
Techno-Science.net on MSNCOVID-19, cancer... towards mass production of artificial antibodies ⚔️Scientists from UNIGE have developed synthetic molecules that mimic antibodies. They could revolutionize the treatment of ...
Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...
Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...
3d
News Medical on MSNStudy reveals new antibody treatment for flesh eating fungus infectionA new study offers hope in the fight against flesh-eating fungus infections. Researchers have discovered a promising antibody ...
An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, ...
Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...
Second-line treatments include a second course of IVGC ... pathway mediated by IGF-1 and related ligands or agonistic antibodies, reducing the expression of downstream inflammatory factors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results